SBRT combined with Tislelizumab followed by Tislelizumab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
5
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Chemotherapy | 2 |
| Hypofractionated Radiotherapy | 2 |
| Lung cancer | 2 |
| NSCLC | 2 |
| Tislelizumab | 2 |
Recruiting trials involving SBRT combined with Tislelizumab followed by Tislelizumab
- Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient
- Tislelizumab Combined With sCRT in Stage IIIB/C-IV Non-Squamous Non-Small Cell Lung Cancer：A Prospective, Single-Arm, Phase II Study
Common questions
How many recruiting trials involve SBRT combined with Tislelizumab followed by Tislelizumab?
2 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.